RIPK3 and kidney disease Juan Guerrero-Mauvecin; Miguel Fontecha-Barriuso; Ana M. López-Diaz; Alberto Ortiz; Ana B. Sanz;

Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease Jose Luis Górriz; José Ramón González-Juanatey; Lorenzo Facila; Maria Jose Soler; Alfonso Valle; Alberto Ortiz;

The role of decoy receptor 3 in inflammation and atherosclerosis in patients with chronic kidney disease and renal transplant patients Saliha Uysal; Aysun Toker; Kültigin Türkmen; Suat Keskin;